title: Bacteremia caused by Mycobacterium wolinskyi.
authors.forename: Yu-Chuan
authors.initials: YC
authors.lastname: Chen
authors.forename: Ruwen
authors.initials: R
authors.lastname: Jou
authors.forename: Wei-Lun
authors.initials: WL
authors.lastname: Huang
authors.forename: Shao-Tsung
authors.initials: ST
authors.lastname: Huang
authors.forename: Keng-Chang
authors.initials: KC
authors.lastname: Liu
authors.forename: Chorng-Jang
authors.initials: CJ
authors.lastname: Lay
authors.forename: Shu-Mei
authors.initials: SM
authors.lastname: Chang
authors.forename: Chih-En
authors.initials: CE
authors.lastname: Tseng
authors.forename: Chun-Liang
authors.initials: CL
authors.lastname: Lai
authors.forename: Yu-Chieh
authors.initials: YC
authors.lastname: Su
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects; D016470:Bacteremia / Q000175:diagnosis* / Q000276:immunology / Q000382:microbiology; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D009165:Mycobacterium Infections, Nontuberculous / Q000175:diagnosis* / Q000209:etiology / Q000276:immunology; D020102:Mycobacterium smegmatis / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D000069283:Rituximab; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab